219 related articles for article (PubMed ID: 17166171)
1. Comparative assessment of four drug interaction compendia.
Vitry AI
Br J Clin Pharmacol; 2007 Jun; 63(6):709-14. PubMed ID: 17166171
[TBL] [Abstract][Full Text] [Related]
2. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.
Wong CM; Ko Y; Chan A
Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481
[TBL] [Abstract][Full Text] [Related]
3. Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia.
Olvey EL; Clauschee S; Malone DC
Clin Pharmacol Ther; 2010 Jan; 87(1):48-51. PubMed ID: 19890252
[TBL] [Abstract][Full Text] [Related]
4. Concordance of severity ratings provided in four drug interaction compendia.
Abarca J; Malone DC; Armstrong EP; Grizzle AJ; Hansten PD; Van Bergen RC; Lipton RB
J Am Pharm Assoc (2003); 2004; 44(2):136-41. PubMed ID: 15098847
[TBL] [Abstract][Full Text] [Related]
5. Lack of drug interaction conformity in commonly used drug compendia for selected at-risk dermatologic drugs.
Chao SD; Maibach HI
Am J Clin Dermatol; 2005; 6(2):105-11. PubMed ID: 15799682
[TBL] [Abstract][Full Text] [Related]
6. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.
Anthony M; Romero K; Malone DC; Hines LE; Higgins L; Woosley RL
Clin Pharmacol Ther; 2009 Oct; 86(4):425-9. PubMed ID: 19587643
[TBL] [Abstract][Full Text] [Related]
7. Comparison of potentially hepatotoxic drugs among major US drug compendia.
Guo JJ; Wigle PR; Lammers K; Vu O
Res Social Adm Pharm; 2005 Sep; 1(3):460-79. PubMed ID: 17138490
[TBL] [Abstract][Full Text] [Related]
8. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.
Wang LM; Wong M; Lightwood JM; Cheng CM
Ann Pharmacother; 2010 Jan; 44(1):28-34. PubMed ID: 20040698
[TBL] [Abstract][Full Text] [Related]
9. Drug interaction microcomputer software evaluation: PDR's drug interactions and side effects diskettes.
Poirier TI; Giudici RA
Hosp Pharm; 1990 Sep; 25(9):839-42, 851. PubMed ID: 10170593
[TBL] [Abstract][Full Text] [Related]
10. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists.
Chan A; Tan SH; Wong CM; Yap KY; Ko Y
Clin Ther; 2009; 31 Pt 2():2379-86. PubMed ID: 20110047
[TBL] [Abstract][Full Text] [Related]
11. Warfarin drug interactions: a comparative evaluation of the lists provided by five information sources.
Martins MA; Carlos PP; Ribeiro DD; Nobre VA; César CC; Rocha MO; Ribeiro AL
Eur J Clin Pharmacol; 2011 Dec; 67(12):1301-8. PubMed ID: 21701882
[TBL] [Abstract][Full Text] [Related]
12. Poor concordance among drug compendia for proposed interactions between enzyme-inducing antiepileptic drugs and direct oral anticoagulants.
Acton EK; Willis AW; Gelfand MA; Kasner SE
Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1534-1538. PubMed ID: 31517414
[TBL] [Abstract][Full Text] [Related]
13. [Quality of interaction database management systems].
Rodríguez-Terol A; Caraballo MO; Palma D; Santos-Ramos B; Molina T; Desongles T; Aguilar A
Farm Hosp; 2009; 33(3):134-46. PubMed ID: 19712597
[TBL] [Abstract][Full Text] [Related]
14. Caveat emptor: Erroneous safety information about opioids in online drug-information compendia.
Talwar SR; Randhawa AS; Dankiewicz EH; Crudele NT; Haddox JD
J Opioid Manag; 2016; 12(4):281-8. PubMed ID: 27575829
[TBL] [Abstract][Full Text] [Related]
15. Drug interactions involving antiepileptic drugs: assessment of the consistency among three drug compendia and FDA-approved labels.
Ekstein D; Tirosh M; Eyal Y; Eyal S
Epilepsy Behav; 2015 Mar; 44():218-24. PubMed ID: 25771206
[TBL] [Abstract][Full Text] [Related]
16. Systematic review: reliability of compendia methods for off-label oncology indications.
Abernethy AP; Raman G; Balk EM; Hammond JM; Orlando LA; Wheeler JL; Lau J; McCrory DC
Ann Intern Med; 2009 Mar; 150(5):336-43. PubMed ID: 19221366
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of resources for analyzing drug interactions.
Patel RI; Beckett RD
J Med Libr Assoc; 2016 Oct; 104(4):290-295. PubMed ID: 27822150
[TBL] [Abstract][Full Text] [Related]
18. Official USP Reference Standards: metrology concepts, overview, and scientific issues and opportunities.
Williams RL; ;
J Pharm Biomed Anal; 2006 Jan; 40(1):3-15. PubMed ID: 16303277
[TBL] [Abstract][Full Text] [Related]
19. Worldwide analysis of factors associated with medicines compendia publishing.
Arguello B; Fernandez-Llimos F
Int J Clin Pharm; 2013 Jun; 35(3):386-92. PubMed ID: 23536106
[TBL] [Abstract][Full Text] [Related]
20. [Drug interaction computer programs: which choice?].
Perrin Y; Buclin T; Biollaz J
Praxis (Bern 1994); 2004 Jun; 93(23):991-6. PubMed ID: 15233567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
